IncobotulinumtoxinA (XEOMIN®)
NMCCL.2022.0029
Phase 3 small_molecule active
Quick answer
IncobotulinumtoxinA (XEOMIN®) for Chronic Migraine is a Phase 3 program (small_molecule) at Camp4 Therapeutics Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Camp4 Therapeutics Corp
- Indication
- Chronic Migraine
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active